TINA BEAN: Open Payments
NPI 1700993698 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 31 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $235 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Amgen Inc. | 4 | $65 |
| Lilly USA, LLC | 2 | $45 |
| Novo Nordisk Inc | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
Products named: AUSTEDO XR, UZEDY, REXULTI, CAPLYTA, OTEZLA, VRAYLAR, JARDIANCE, HETLIOZ.
Industry payments across NC — which companies pay providers there.
